PL4285902T3 - Wzmocniona kwaśna α-glukozydaza do leczenia choroby Pompego - Google Patents
Wzmocniona kwaśna α-glukozydaza do leczenia choroby PompegoInfo
- Publication number
- PL4285902T3 PL4285902T3 PL23188938.7T PL23188938T PL4285902T3 PL 4285902 T3 PL4285902 T3 PL 4285902T3 PL 23188938 T PL23188938 T PL 23188938T PL 4285902 T3 PL4285902 T3 PL 4285902T3
- Authority
- PL
- Poland
- Prior art keywords
- glucosidase
- treatment
- pompe disease
- enhanced acid
- enhanced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/0102—Alpha-glucosidase (3.2.1.20)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562272890P | 2015-12-30 | 2015-12-30 | |
| US201662300479P | 2016-02-26 | 2016-02-26 | |
| US201662315412P | 2016-03-30 | 2016-03-30 | |
| US201662402454P | 2016-09-30 | 2016-09-30 | |
| US201662428867P | 2016-12-01 | 2016-12-01 | |
| US201662431791P | 2016-12-08 | 2016-12-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4285902T3 true PL4285902T3 (pl) | 2026-04-13 |
Family
ID=60186557
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21174249.9T PL3957320T3 (pl) | 2015-12-30 | 2016-12-29 | Wzmocniona kwaśna alfa-glukozydaza do leczenia choroby Pompego |
| PL23188938.7T PL4285902T3 (pl) | 2015-12-30 | 2016-12-29 | Wzmocniona kwaśna α-glukozydaza do leczenia choroby Pompego |
| PL16826898T PL3397273T3 (pl) | 2015-12-30 | 2016-12-29 | Wzmocniona kwaśna α-glukozydaza do leczenia choroby Pompego |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21174249.9T PL3957320T3 (pl) | 2015-12-30 | 2016-12-29 | Wzmocniona kwaśna alfa-glukozydaza do leczenia choroby Pompego |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16826898T PL3397273T3 (pl) | 2015-12-30 | 2016-12-29 | Wzmocniona kwaśna α-glukozydaza do leczenia choroby Pompego |
Country Status (16)
| Country | Link |
|---|---|
| EP (4) | EP3397273B1 (pl) |
| CN (1) | CN108472340A (pl) |
| CY (1) | CY1124637T1 (pl) |
| DK (3) | DK3957320T5 (pl) |
| ES (3) | ES2965190T3 (pl) |
| FI (2) | FI4285902T3 (pl) |
| HK (1) | HK1253014A1 (pl) |
| HR (3) | HRP20231465T1 (pl) |
| HU (2) | HUE064049T2 (pl) |
| LT (3) | LT3957320T (pl) |
| PL (3) | PL3957320T3 (pl) |
| PT (3) | PT4285902T (pl) |
| RS (3) | RS64843B1 (pl) |
| SI (3) | SI3957320T1 (pl) |
| SM (3) | SMT202600054T1 (pl) |
| TW (3) | TWI849380B (pl) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7723296B2 (en) * | 2001-01-18 | 2010-05-25 | Genzyme Corporation | Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
| EP2857036B1 (en) | 2003-01-31 | 2016-12-21 | Mount Sinai School of Medicine of New York University | Combination therapy for treating protein deficiency disorders |
| CA2553955C (en) * | 2004-02-10 | 2012-08-28 | Zystor Therapeutics, Inc. | Acid alpha-glucosidase and fragments thereof |
| EP3782655A1 (en) | 2005-05-17 | 2021-02-24 | Amicus Therapeutics, Inc. | A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives |
| EP2946785B1 (en) | 2008-02-12 | 2018-10-24 | Amicus Therapeutics, Inc. | Method to predict response to pharmacological chaperone treatment of diseases |
| AU2010254092B2 (en) * | 2009-05-26 | 2015-11-12 | Amicus Therapeutics, Inc. | Utilization of pharmacological chaperones to improve manufacturing and purification of biologics |
| SMT202100136T1 (it) | 2012-05-03 | 2021-05-07 | Amicus Therapeutics Inc | Regimi posologici per il trattamento della malattia di pompe |
| WO2014014938A1 (en) | 2012-07-17 | 2014-01-23 | Amicus Therapeutics, Inc. | Alpha-galactosidase a and 1-deoxygalactonojirimycin co-formulation |
| CN114540327B (zh) * | 2014-09-30 | 2026-03-24 | 阿米库斯治疗学公司 | 具有增强的碳水化合物的高强度酸性α-葡糖苷酶 |
-
2016
- 2016-12-29 HR HRP20231465TT patent/HRP20231465T1/hr unknown
- 2016-12-29 RS RS20231076A patent/RS64843B1/sr unknown
- 2016-12-29 ES ES21174249T patent/ES2965190T3/es active Active
- 2016-12-29 HU HUE21174249A patent/HUE064049T2/hu unknown
- 2016-12-29 PL PL21174249.9T patent/PL3957320T3/pl unknown
- 2016-12-29 HU HUE16826898A patent/HUE054733T2/hu unknown
- 2016-12-29 EP EP16826898.5A patent/EP3397273B1/en active Active
- 2016-12-29 SI SI201631766T patent/SI3957320T1/sl unknown
- 2016-12-29 CN CN201680077801.5A patent/CN108472340A/zh active Pending
- 2016-12-29 DK DK21174249.9T patent/DK3957320T5/da active
- 2016-12-29 PT PT231889387T patent/PT4285902T/pt unknown
- 2016-12-29 EP EP21174249.9A patent/EP3957320B1/en active Active
- 2016-12-29 FI FIEP23188938.7T patent/FI4285902T3/fi active
- 2016-12-29 SM SM20260054T patent/SMT202600054T1/it unknown
- 2016-12-29 SM SM20210452T patent/SMT202100452T1/it unknown
- 2016-12-29 LT LTEP21174249.9T patent/LT3957320T/lt unknown
- 2016-12-29 HK HK18112390.1A patent/HK1253014A1/zh unknown
- 2016-12-29 HR HRP20260120TT patent/HRP20260120T1/hr unknown
- 2016-12-29 DK DK23188938.7T patent/DK4285902T3/da active
- 2016-12-29 PL PL23188938.7T patent/PL4285902T3/pl unknown
- 2016-12-29 PT PT211742499T patent/PT3957320T/pt unknown
- 2016-12-29 ES ES16826898T patent/ES2883844T3/es active Active
- 2016-12-29 RS RS20260146A patent/RS67727B1/sr unknown
- 2016-12-29 FI FIEP21174249.9T patent/FI3957320T3/fi active
- 2016-12-29 PT PT168268985T patent/PT3397273T/pt unknown
- 2016-12-29 DK DK16826898.5T patent/DK3397273T3/da active
- 2016-12-29 ES ES23188938T patent/ES3063549T3/es active Active
- 2016-12-29 PL PL16826898T patent/PL3397273T3/pl unknown
- 2016-12-29 LT LTEP23188938.7T patent/LT4285902T/lt unknown
- 2016-12-29 SI SI201631258T patent/SI3397273T1/sl unknown
- 2016-12-29 EP EP23188938.7A patent/EP4285902B1/en active Active
- 2016-12-29 HR HRP20210894TT patent/HRP20210894T1/hr unknown
- 2016-12-29 EP EP25215448.9A patent/EP4706779A2/en active Pending
- 2016-12-29 LT LTEP16826898.5T patent/LT3397273T/lt unknown
- 2016-12-29 SI SI201631944T patent/SI4285902T1/sl unknown
- 2016-12-29 SM SM20230412T patent/SMT202300412T1/it unknown
- 2016-12-29 RS RS20210984A patent/RS62212B1/sr unknown
- 2016-12-30 TW TW111105262A patent/TWI849380B/zh active
- 2016-12-30 TW TW105144116A patent/TWI753874B/zh active
- 2016-12-30 TW TW113123576A patent/TW202506173A/zh unknown
-
2021
- 2021-08-06 CY CY20211100705T patent/CY1124637T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283837A (en) | Augmented acid alpha-glucosidase for the treatment of pompe disease | |
| LT3334422T (lt) | Kanabidiolio rūgšties panaudojimas epilepsijos gydymui | |
| HUE053115T2 (hu) | Topikális gyógyszerészeti formulációk gyulladással összefüggõ állapotok kezelésére | |
| HUE059662T2 (hu) | Eljárás terápiás immunsejtek hatékonyságának fokozására | |
| IL262211A (en) | Gene therapy for treating mucopolysaccharidosis type ii | |
| HUE049323T2 (hu) | Hízósejt-stabilizálók tüdõbetegség kezelésére | |
| PL3169328T3 (pl) | Pochodne chinoliny do leczenia chorób zapalnych | |
| LT3390390T (lt) | Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui | |
| BR112016021012A2 (pt) | composições farmacêuticas de compostos terapeuticamente ativos. | |
| IL256206A (en) | Mct4 inhibitors for treating disease | |
| HUE060517T2 (hu) | Immunhiányos betegség kezelésére szolgáló eljárások | |
| HUE053443T2 (hu) | Heteroaril vegyületek szembetegségek kezelésére | |
| IL257355B (en) | Selection of patients for combination therapy | |
| LT3119384T (lt) | Intrahepatinių cholestazinių ligų gydymas | |
| IL257764B (en) | Methods for treatment of diseases | |
| HUE063820T2 (hu) | Módszerek kardiovaszkuláris betegségek kezelésére | |
| BR112016015712A2 (pt) | método de tratamento de doenças hepáticas. | |
| IL259381B (en) | Mirabegron for the treatment of retinal diseases | |
| KR20180085033A (ko) | 피부 질환 치료용 약학적 제형 및 이의 제조 방법 | |
| LT3322438T (lt) | Il-8 inhibitoriai, skirti naudoti tam tikrų urologinių susirgimų gydymui | |
| IL256919A (en) | Pharmaceutical compositions useful for the treatment of tissue injury | |
| KR101583452B9 (ko) | 위장질환 치료용 의약 조성물 | |
| PL4285902T3 (pl) | Wzmocniona kwaśna α-glukozydaza do leczenia choroby Pompego | |
| LT3319586T (lt) | Farmaciniai preparatai, skirti tiesiosios žarnos uždegiminių ligų gydymui |